Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
GlaxoSmithKline (GSK)
Share Price: 1,555.00p Change Today: -11.00p  Market Cap: 77,227m

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 31,826.80 7,630.89 110.12p 14.1 n/a -8% 79.97p 5.3%
31-Dec-20 34,185.39 8,253.22 115.37p 13.5 2.8 +5% 79.97p 5.3%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
11-Mar-19 Transfer From Victoria Whyte 0.000p 8 0.00
11-Mar-19 Buy Victoria Whyte 1,527.59p 8 122.21
11-Mar-19 Transfer From David Redfern 0.000p 8 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Price Data

Currency UK Pounds
Share Price 1,555.00p
Change Today -11.00p
% Change -0.70 %
Volume 9,062,799
22-Mar-19 Close 1,555.00p
Shares Issued 4,966.39m
Market Cap 77,227m
Year End 31-Dec-18

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 14
Sell 0
Strong Sell 2
Total 19
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q4 Q3
Ex-Div 21-Feb-19 15-Nov-18
Paid 11-Apr-19 10-Jan-19
Amount 23.00p 19.00p

Trades for 22-Mar-2019

Time Volume / Share Price
16:39 2,180 @ 1,555.00p
16:39 5,000 @ 1,555.00p
16:39 5,000 @ 1,555.00p
16:38 602 @ 1,555.00p
16:38 200 @ 1,555.00p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley



www.bolsamania.com www.sharecast.com http://www.proshareclubs.co.uk/ www.digitallook.com